AUGMENT: A Phase Iii Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma

AuthID
 P-00Q-M57
22
Author(s)
Leonard, JP
·
Izutsu, K
·
Fowler, NH
·
Hong, X
·
Zhu, J
·
Zhang, H
·
Offner, F
·
Nowakowski, GS
·
[+2]·
Fogliatto, LM
·
Scheinberg, P
·
Flinn, IW
·
Moreira, C
·
Cabeçadas, J
·
Liu, D
·
Fustier, P
·
Wu, C
·
Gribben, JG
View all authors
1
Group Author(s)
AUGMENT Trial Investigators
Document Type
Article
Year published
2019
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 37, Issue: 14, Pages: 1188-+ (26)
Indexing
Wos®
Scopus®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 30897038
Scopus: 2-s2.0-85065810047
Wos: WOS:000468265800008
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.
All authors
Name Order Name   Name Order Name   Name Order Name
1 Leonard, JP;   2 Trneny, M;   3 Izutsu, K;
4 Fowler, NH;   5 Hong, X;   6 Zhu, J;
7 Zhang, H;   8 Offner, F;   9 Scheliga, A;
10 Nowakowski, GS;   11 Pinto, A;   12 Re, F;
13 Fogliatto, LM;   14 Scheinberg, P;   15 Flinn, IW;
16 Moreira, C;   17 Cabeçadas, J;   18 Liu, D;
19 Kalambakas, S;   20 Fustier, P;   21 Wu, C;
22 Gribben, JG;    

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service